Activation of astrocytes with an increased expression of GFAP and S100β is a hallmark of brain diseases, including common late-onset neurodegenerative diseases, ischemic brain injuries, and epilepsy27,30,43,44. The gene discussed is GFAP; the disease is neurodegenerative disease.